{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:27:22Z","timestamp":1790692042195,"version":"4.1.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,15]],"date-time":"2020-01-15T00:00:00Z","timestamp":1579046400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,15]],"date-time":"2020-01-15T00:00:00Z","timestamp":1579046400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Universidad UTE"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Although cannabis and cannabinoids are widely used with therapeutic purposes, their claimed efficacy is highly controversial. For this reason, medical cannabis use is a broad field of research that is rapidly expanding. Our objectives are to identify, characterize, appraise, and organize the current available evidence surrounding therapeutic use of cannabis and cannabinoids, using evidence maps.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We searched PubMed, EMBASE, The Cochrane Library and CINAHL, to identify systematic reviews (SRs) published from their inception up to December 2017. Two authors assessed eligibility and extracted data independently. We assessed methodological quality of the included SRs using the AMSTAR tool. To illustrate the extent of use of medical cannabis, we organized the results according to identified PICO questions using bubble plots corresponding to different clinical scenarios.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 44 SRs published between 2001 and 2017 were included in this evidence mapping with data from 158 individual studies. We extracted 96 PICO questions in the following medical conditions: multiple sclerosis, movement disorders (e.g. Tourette Syndrome, Parkinson Disease), psychiatry conditions, Alzheimer disease, epilepsy, acute and chronic pain, cancer, neuropathic pain, symptoms related to cancer (e.g. emesis and anorexia related with chemotherapy), rheumatic disorders, HIV-related symptoms, glaucoma, and COPD. The evidence about these conditions is heterogeneous regarding the conclusions and the quality of the individual primary studies. The quality of the SRs was moderate to high according to AMSTAR scores.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Evidence on medical uses of cannabis is broad. However, due to methodological limitations, conclusions were weak in most of the assessed comparisons. Evidence mapping methodology is useful to perform an overview of available research, since it is possible to systematically describe the extent and distribution of evidence, and to organize scattered data.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12906-019-2803-2","type":"journal-article","created":{"date-parts":[[2020,1,15]],"date-time":"2020-01-15T14:02:52Z","timestamp":1579096972000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Therapeutic use of cannabis and cannabinoids: an evidence mapping and appraisal of systematic reviews"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5375-3781","authenticated-orcid":false,"given":"Nadia","family":"Montero-Oleas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Arevalo-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solange","family":"Nu\u00f1ez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"Viteri-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Simancas-Racines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,15]]},"reference":[{"issue":"24","key":"2803_CR1","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1001\/jama.2015.6358","volume":"313","author":"PF Whiting","year":"2015","unstructured":"Whiting PF, Wolff RF, Deshpande S, Di NM, Duffy S, Hernandez AV, et al. Cannabinoids for medical use a systematic review and meta-analysis. JAMA. 2015;313(24):2456\u201373.","journal-title":"JAMA."},{"issue":"3","key":"2803_CR2","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3109\/07853890.2016.1145794","volume":"48","author":"RJ Schrot","year":"2016","unstructured":"Schrot RJ, Hubbard JR. Cannabinoids : Medical implications. Ann Med. 2016;48(3):128\u201341.","journal-title":"Ann Med"},{"issue":"2","key":"2803_CR3","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.mayocp.2011.10.003","volume":"87","author":"JM Bostwick","year":"2012","unstructured":"Bostwick JM. Blurred boundaries : the therapeutics and politics of medical marijuana. Mayo Clin Proc. 2012;87(2):172\u201386 Available from: https:\/\/doi.org\/10.1016\/j.mayocp.2011.10.003.","journal-title":"Mayo Clin Proc"},{"key":"2803_CR4","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.lfs.2019.03.053","volume":"224","author":"M Premoli","year":"2019","unstructured":"Premoli M, Aria F, Bonini SA, Maccarinelli G, Gianoncelli A, Della Pina S, Tambaro S, Memo M, Mastinu A. Cannabidiol: recent advances and new insights for neuropsychiatric disorders treatment. Life Sci. 2019;224:120\u20137.","journal-title":"Life Sci"},{"issue":"6","key":"2803_CR5","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1007\/s00425-019-03138-x","volume":"249","author":"Amit Kumar","year":"2019","unstructured":"Kumar A, Premoli M, Aria F, Bonini SA, Maccarinelli G, Gianoncelli A, Memo M, Mastinu A. Cannabimimetic plants: are they new cannabinoidergic modulators? Planta. 2019. https:\/\/doi.org\/10.1007\/s00425-019-03138-x.","journal-title":"Planta"},{"issue":"3","key":"2803_CR6","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.tips.2016.12.002","volume":"38","author":"S Pisanti","year":"2017","unstructured":"Pisanti S, Bifulco M. Modern history of medical cannabis: from widespread use to prohibitionism and back. Trends Pharmacol Sci. 2017;38(3):195\u20138 Available from: https:\/\/doi.org\/10.1016\/j.tips.2016.12.002.","journal-title":"Trends Pharmacol Sci"},{"key":"2803_CR7","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1056\/NEJMra1402309","volume":"370","author":"N Volkow","year":"2014","unstructured":"Volkow N, Baler R, Compton W, Weiss S. Adverse health effects of marijuana use. N Engl J Med. 2014;370:2219\u201327.","journal-title":"N Engl J Med"},{"issue":"2","key":"2803_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2522\/ptj.20160367","volume":"97","author":"CD Ciccone","year":"2017","unstructured":"Ciccone CD. Medical marijuana : just the beginning of a long, strange trip? Phys Ther. 2017;97(2):1\u201310.","journal-title":"Phys Ther"},{"issue":"2","key":"2803_CR9","doi-asserted-by":"publisher","first-page":"130","DOI":"10.15252\/embr.201439742","volume":"16","author":"M Bifulco","year":"2015","unstructured":"Bifulco M, Pisanti S. Medicinal use of cannabis in Europe. EMBO Rep. 2015;16(2):130\u20132.","journal-title":"EMBO Rep"},{"key":"2803_CR10","unstructured":"Aguilar BS, Guti\u00e9rrez V, S\u00e1nchez L, Nougier M. Medicinal cannabis policies and practices around the world. Int Drug Policy Consort. Briefing paper. 2018;(April):1\u201332."},{"key":"2803_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajo.2017.03.006","volume":"177","author":"MF Lieberman","year":"2017","unstructured":"Lieberman MF. \u201cRecredicinal\u201d marijuana. Am J Ophthalmol. 2017;177:1\u20134.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"2803_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2288-11-92","volume":"11","author":"P Bragge","year":"2011","unstructured":"Bragge P, Clavisi O, Turner T, Tavender E, Collie A, Gruen RL. The global evidence mapping initiative: scoping research in broad topic areas. BMC Med Res Methodol. 2011;11(1):1\u201312.","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"2803_CR13","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12874-017-0402-9","volume":"17","author":"M Ballesteros","year":"2017","unstructured":"Ballesteros M, Montero N, L\u00f3pez-Pousa A, Urr\u00fatia G, Sol\u00e0 I, Rada G, et al. Evidence mapping based on systematic reviews of therapeutic interventions for gastrointestinal stromal tumors (GIST). BMC Med Res Methodol. 2017;17(1):135.","journal-title":"BMC Med Res Methodol"},{"key":"2803_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2050312118801710","volume":"6","author":"I Arevalo-Rodriguez","year":"2018","unstructured":"Arevalo-Rodriguez I, Mu\u00f1oz E, Buitrago-Garcia D, Nu\u00f1ez-Gonz\u00e1lez S, Montero-Oleas N, Garz\u00f3n V, et al. Quality assessment of controlled clinical trials published in orthopaedics and traumatology journals in Spanish: an observational study through handsearching and evidence mapping. SAGE Open Med. 2018;6:1\u20139.","journal-title":"SAGE Open Med"},{"issue":"10","key":"2803_CR15","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1007\/s12094-019-02069-z","volume":"21","author":"M. Ballesteros","year":"2019","unstructured":"Ballesteros M, Montero N, L\u00f3pez-Pousa A, Urr\u00fatia G, Sol\u00e0 I, Rada G, et al. Evidence mapping based on systematic reviews of therapeutic interventions for soft tissue sarcomas. Clin Transl Oncol. 2019;21(10):1398\u20131412.","journal-title":"Clinical and Translational Oncology"},{"issue":"2","key":"2803_CR16","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/phar.1187","volume":"22","author":"LM Borgelt","year":"2013","unstructured":"Borgelt LM, Franson KL, Nussbaum AM, Wang GS. The pharmacologic and clinical effects of medical cannabis. Pharmacotherapy. 2013;22(2):195\u2013209.","journal-title":"Pharmacotherapy."},{"key":"2803_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2288-7-10","volume":"7","author":"BJ Shea","year":"2007","unstructured":"Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N, Hamel C, et al. Development of AMSTAR : a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol. 2007;7:1\u20137.","journal-title":"BMC Med Res Methodol"},{"key":"2803_CR18","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/bju.13759","volume":"119","author":"NA Youssef","year":"2017","unstructured":"Youssef NA, Schneider MP, Mordasini L, Ineichen BV, Bachmann LM, Chartier-kastler E, et al. Cannabinoids for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis : a systematic review and meta-analysis. BJU Int. 2017;119:515\u201321.","journal-title":"BJU Int"},{"issue":"13","key":"2803_CR19","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1503\/cmaj.071178","volume":"178","author":"T Wang","year":"2008","unstructured":"Wang T, Collet J-P, Shapiro S, Ware M. Adverse effects of medical cannabinoids: a systematic review. C Can Med Assoc J. 2008;178(13):1669\u201378.","journal-title":"C Can Med Assoc J"},{"issue":"10","key":"2803_CR20","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s11940-014-0314-5","volume":"16","author":"D Bega","year":"2014","unstructured":"Bega D, Gonzalez-latapi P, Zadikoff C, Simuni T. A review of the clinical evidence for complementary and alternative therapies in Parkinson\u2019s disease. Curr Treat Options Neurol. 2014;16(10):314.","journal-title":"Curr Treat Options Neurol"},{"issue":"1","key":"2803_CR21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.11607\/ofph.1274","volume":"29","author":"DG Boychuk","year":"2015","unstructured":"Boychuk DG, States U, Paul S, Goddard G. The effectiveness of cannabinoids in the management of chronic nonmalignant neuropathic pain: a systematic review. J Oral Facial Pain Headache. 2015;29(1):7\u201314.","journal-title":"J Oral Facial Pain Headache"},{"issue":"4","key":"2803_CR22","first-page":"449","volume":"9","author":"M Khaiser","year":"2016","unstructured":"Khaiser M, Pharmd C, Peng M, Pharmd C, Ahrari S, Mscphm C, et al. Medical cannabis dosing strategies in pain-related conditions: a scoping review of current literature. J Pain Manag. 2016;9(4):449\u201363.","journal-title":"J Pain Manag"},{"key":"2803_CR23","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1212\/WNL.0000000000000363","volume":"82","author":"BS Koppel","year":"2014","unstructured":"Koppel BS, Fife T, Youssof S. Systematic review : efficacy and safety of medical marijuana in selected neurologic disorders. Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2014;82:1556\u201363.","journal-title":"Neurology."},{"issue":"11","key":"2803_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1352458516643600","volume":"22","author":"S Otero-Romero","year":"2016","unstructured":"Otero-Romero S, Sastre-Garriga J, Comi G, Hartung H, S\u00f8rensen PS, Thompson AJ, et al. Pharmacological management of spasticity in multiple sclerosis : systematic review and consensus paper. Mult Scler J. 2016;22(11):1\u201311.","journal-title":"Mult Scler J"},{"key":"2803_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmj.323.7303.1","volume":"323","author":"FA Campbell","year":"2001","unstructured":"Campbell FA, Tram\u00e8r MR, Carroll D, Reynolds DJM, Moore RA. Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review. BMJ. 2001;323:1\u20136.","journal-title":"BMJ."},{"key":"2803_CR26","doi-asserted-by":"crossref","unstructured":"Curtis A, Clarke C, Rickards H. Cannabinoids for Tourette \u2019 s syndrome (review). Cochrane Database Syst Rev. 2009;(4):1\u201313.","DOI":"10.1002\/14651858.CD006565.pub2"},{"key":"2803_CR27","doi-asserted-by":"crossref","unstructured":"De Souza S, Desantana JM, Kenji F, Nogueira \u00ca, Lira da Silva D, Ara\u00fajo-J\u00fanior JX, et al. Efficacy and safety of medicinal plants or related natural products for fibromyalgia: a systematic review. Evidence-Based Complement Altern Med. 2013;2013:1\u201310.","DOI":"10.1155\/2013\/149468"},{"key":"2803_CR28","first-page":"372","volume":"61","author":"A Deshpande","year":"2015","unstructured":"Deshpande A, Mailis-gagnon A, Zoheiry N, Lakha S. Efficacy and adverse effects of medical marijuana for chronic noncancer pain. Can Fam Physician. 2015;61:372\u201381.","journal-title":"Can Fam Physician"},{"issue":"1","key":"2803_CR29","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1185\/030079906X158066","volume":"23","author":"M Iskedjian","year":"2007","unstructured":"Iskedjian M, Bereza B, Gordon A. Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain. Curr Med Res Opin. 2007;23(1):17\u201324.","journal-title":"Curr Med Res Opin"},{"key":"2803_CR30","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1007\/s40265-013-0125-0","volume":"73","author":"R Jawahar","year":"2013","unstructured":"Jawahar R, Oh U, Yang S, Lapane KL. A systematic review of pharmacological pain management in multiple sclerosis. Drugs. 2013;73:1711\u201322.","journal-title":"Drugs."},{"issue":"1","key":"2803_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2377-9-59","volume":"9","author":"SE Lakhan","year":"2009","unstructured":"Lakhan SE, Rowland M. Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis: a systematic review. BMC Neurol. 2009;9(1):1\u20136.","journal-title":"BMC Neurol"},{"key":"2803_CR32","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.arr.2014.01.007","volume":"14","author":"GA Van Den Elsen","year":"2014","unstructured":"Van Den Elsen GA, Ahmed AIA, Lammers M, Kramers C, Verkes RJ, Van Der Marck MA, et al. Efficacy and safety of medical cannabinoids in older subjects: a systematic review. Ageing Res Rev. 2014;14:56\u201364.","journal-title":"Ageing Res Rev"},{"issue":"1","key":"2803_CR33","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1093\/ecco-jcc\/jju007","volume":"9","author":"J Langhorst","year":"2015","unstructured":"Langhorst J, Wulfert H, Lauche R. Systematic review of complementary and alternative medicine treatments in inflammatory bowel diseases. J Crohn's Colitis. 2015;9(1):86\u2013106.","journal-title":"J Crohn's Colitis"},{"key":"2803_CR34","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/j.1365-2354.2008.00917.x","volume":"17","author":"F Machado","year":"2008","unstructured":"Machado F, Stefano S, De Cassia R, Rosa L, Da Silveira D. Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients : systematic review and meta-analysis. Eur J Cancer Care (Engl). 2008;17:431\u201343.","journal-title":"Eur J Cancer Care (Engl)"},{"issue":"8","key":"2803_CR35","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1111\/j.1526-4637.2009.00703.x","volume":"10","author":"E Mart\u00edn-S\u00e1nchez","year":"2009","unstructured":"Mart\u00edn-S\u00e1nchez E, Furukawa TA, Taylor J, Martin JLR. Systematic review and meta-analysis of Cannabis treatment for chronic pain. Pain Med. 2009;10(8):1353\u201368.","journal-title":"Pain Med"},{"issue":"8","key":"2803_CR36","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1016\/j.apmr.2015.12.023","volume":"97","author":"S Mehta","year":"2016","unstructured":"Mehta S, Mcintyre A, Janzen S, Loh E, Teasell R. A systematic review of pharmacological treatments of pain after spinal cord injury: an update. Arch Phys Med Rehabil. 2016;97(8):1381.","journal-title":"Arch Phys Med Rehabil"},{"issue":"5","key":"2803_CR37","doi-asserted-by":"publisher","first-page":"706","DOI":"10.3109\/02699051003692126","volume":"24","author":"MJ Meyer","year":"2010","unstructured":"Meyer MJ, Megyesi J, Meythaler J, Murie-fernandez M, Aubut J, Foley N, et al. Acute management of acquired brain injury part II: an evidence-based review of pharmacological interventions. Brain Inj. 2010;24(5):706\u201321.","journal-title":"Brain Inj"},{"issue":"12","key":"2803_CR38","doi-asserted-by":"publisher","first-page":"e14433","DOI":"10.1371\/journal.pone.0014433","volume":"5","author":"TJC Phillips","year":"2010","unstructured":"Phillips TJC, Cherry CL, Cox S, Marshall SJ, Rice ASC. Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta- analysis of randomised controlled trials. PLoS One. 2010;5(12):e14433.","journal-title":"PLoS One"},{"issue":"2","key":"2803_CR39","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/papr.12054","volume":"14","author":"SJ Snedecor","year":"2014","unstructured":"Snedecor SJ, Sudharshan L, Cappelleri JC, Sadosky A, Mehta S, Botteman M. Systematic review and meta-analysis of pharmacological therapies for painful diabetic peripheral neuropathy. Pain Pract. 2014;14(2):167\u201384.","journal-title":"Pain Pract"},{"issue":"3","key":"2803_CR40","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/aas.12851","volume":"61","author":"AJ Stevens","year":"2017","unstructured":"Stevens AJ, Higgins MD. A systematic review of the analgesic efficacy of cannabinoid medications in the management of acute pain. Acta Anaesthesiol Scand. 2017;61(3):268\u201380.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"5","key":"2803_CR41","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.apmr.2010.01.022","volume":"91","author":"RW Teasell","year":"2011","unstructured":"Teasell RW, Mehta S, Aubut JL, Foulon B, Wolfe DL, Hsieh JTC, et al. A systematic review of pharmacological treatments of pain following spinal cord injury. Arch Phys Med Rehabil. 2011;91(5):816\u201331.","journal-title":"Arch Phys Med Rehabil"},{"issue":"7303","key":"2803_CR42","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1136\/bmj.323.7303.16","volume":"323","author":"MR Tram\u00e8r","year":"2001","unstructured":"Tram\u00e8r MR, Carroll D, Campbell FA, Reynolds DJM, Moore RA. Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review. BMJ. 2001;323(7303):16.","journal-title":"BMJ"},{"issue":"1","key":"2803_CR43","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00482-015-0087-0","volume":"30","author":"M Volz","year":"2016","unstructured":"Volz M, Siegmund B, Hauser W. Efficacy, tolerability, and safety of cannabinoids in gastroenterology. A systematic review. Schmerz. 2016;30(1):37\u201346.","journal-title":"Schmerz."},{"key":"2803_CR44","unstructured":"Amato L, Davoli M, Minozzi S, Mitrova Z, Parmelli E, Saulle R, et al. Systematic reviews on therapeutic efficacy and safety of Cannabis (including extracts and tinctures) for patients with multiple sclerosis, chronic neuropathic pain, dementia and Tourette syndrome, HIV \/ AIDS, and cancer receiving chemotherapy. Epidemiol Prev\u00a02017;41(5-6):279\u2013293."},{"issue":"12","key":"2803_CR45","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.jpain.2015.07.009","volume":"16","author":"MH Andreae","year":"2016","unstructured":"Andreae MH, Carter GM, Shaparin N, Suslov K, Ronald J, Ware MA, et al. Inhaled cannabis for chronic neuropathic pain: an individual patient data meta-analysis. J Pain. 2016;16(12):1221\u201332.","journal-title":"J Pain"},{"key":"2803_CR46","unstructured":"Baldinger R, Hd K, Weber M. Treatment for cramps in amyotrophic lateral sclerosis\/motor neuron disease (review). Cochrane Database Syst Rev. 2012;4:1\u201356"},{"issue":"5","key":"2803_CR47","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1002\/acr.22727","volume":"68","author":"M Fitzcharles","year":"2016","unstructured":"Fitzcharles M, Ste-marie PA, Auser WH, Clauw DJ, Jamal S, Karsh J, et al. Efficacy, tolerability , and safety of cannabinoid treatments in the rheumatic diseases : a systematic review of randomized controlled trials. Arthritis Care Res. 2016;68(5):681\u20138.","journal-title":"Arthritis Care Res"},{"issue":"1","key":"2803_CR48","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00482-015-0084-3","volume":"30","author":"MA Fitzcharles","year":"2016","unstructured":"Fitzcharles MA, Baerwald C, Ablin JWH. Efficacy , tolerability and safety of cannabinoids in chronic pain associated with rheumatic diseases ( fibromyalgia syndrome , back pain, osteoarthritis, rheumatoid arthritis ) a systematic review of randomized controlled trials. Der Schnerz. 2016;30(1):47\u201361.","journal-title":"Der Schnerz"},{"issue":"2","key":"2803_CR49","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","volume":"14","author":"NB Finnerup","year":"2016","unstructured":"Finnerup NB, Attal N, Haroutounian S, Moore A, Raja SN, Rice ASC. Pharmacotherapy for neuropathic pain in adults: systematic review, meta-analysis and updated NeuPSIG recommendations. Lancet Neurol. 2016;14(2):162\u201373.","journal-title":"Lancet Neurol"},{"issue":"2","key":"2803_CR50","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s11481-015-9600-6","volume":"10","author":"ME Lynch","year":"2015","unstructured":"Lynch ME, Ware MA. Cannabinoids for the treatment of chronic non-cancer pain: an updated systematic review of randomized controlled trials. J NeuroImmune Pharmacol. 2015;10(2):293\u2013301.","journal-title":"J NeuroImmune Pharmacol"},{"issue":"5","key":"2803_CR51","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1111\/j.1365-2125.2011.03970.x","volume":"72","author":"ME Lynch","year":"2011","unstructured":"Lynch ME, Campbell F. Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials. Br J Clin Pharmacol. 2011;72(5):735\u201344.","journal-title":"Br J Clin Pharmacol"},{"key":"2803_CR52","unstructured":"Phillips R, Friend A, Gibson F, Houghton E, Gopaul S, Jv C, et al. Antiemetic medication for prevention and treatment of chemotherapy-induced nausea and vomiting in childhood (review). Cochrane Database Syst Rev. 2016;2:1\u201394"},{"key":"2803_CR53","unstructured":"Richards B, Whittle S, Buchbinder R. Neuromodulators for pain management in rheumatoid arthritis (review). Cochrane Database Syst Rev. 2012;1:1\u201351."},{"key":"2803_CR54","unstructured":"Shakespeare D, Boggild M, Ca Y. Anti-spasticity agents for multiple sclerosis (review). Cochrane Database Syst Rev. 2003;4:1\u201337."},{"key":"2803_CR55","unstructured":"Smith L, Azariah F, Lavender V, Stoner N, Bettiol S. Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy (review). Cochrane Database Syst Rev. 2015;11:1\u201381."},{"issue":"1","key":"2803_CR56","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00482-015-0085-2","volume":"30","author":"M Mucke","year":"2016","unstructured":"Mucke M, Carter C, Cuhls H, Prub M, Radbruch L, Hauser W. Cannabinoide in der palliativen Versorgung Systematische. Schmerz. 2016;30(1):25\u201336.","journal-title":"Schmerz"},{"issue":"1","key":"2803_CR57","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s00482-015-0089-y","volume":"30","author":"F Petzke","year":"2016","unstructured":"Petzke F, Enax-Krumova E, Hause W. Wirksamkeit, Vertr\u00e4glichkeit und Sicherheit von Cannabinoiden bei neuropathischen Schmerzsyndromen. Schmerz. 2016;30(1):62\u201388.","journal-title":"Schmerz"},{"key":"2803_CR58","unstructured":"Krishnan S, Cairns R, Howard R. Cannabinoids for the treatment of dementia (review). Cochrane Database Syst Rev. 2009;2:1\u201320."},{"key":"2803_CR59","unstructured":"Gloss D, Vickrey B. Cannabinoids for epilepsy (review). Cochrane Database Syst Rev. 2014;3:1\u201321."},{"key":"2803_CR60","unstructured":"Lutge E, Gray A, Siegfried N. The medical use of cannabis for reducing morbidity and mortality in patients with HIV\/AIDS (review). Cochrane Database Syst Rev. 2013;4:1\u201335."},{"issue":"3","key":"2803_CR61","first-page":"37","volume":"45","author":"H Arno","year":"2013","unstructured":"Arno H, Mark W, Kirsten M-V, Donald A, Franjo G. The medicinal use of cannabis and cannabinoids \u2014 an international cross-sectional survey on adiminstration forms. J Psychoactive Drugs. 2013;45(3):37\u201341.","journal-title":"J Psychoactive Drugs"},{"key":"2803_CR62","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.drugpo.2017.01.011","volume":"42","author":"P Lucas","year":"2017","unstructured":"Lucas P, Walsh Z. Medical cannabis access, use, and substitution for prescription opioids and other substances: a survey of authorized medical cannabis patients. Int J Drug Policy. 2017;42:30\u20135.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"2803_CR63","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1089\/can.2016.0007","volume":"1","author":"Michelle Sexton","year":"2016","unstructured":"Sexton M, Cuttler C, Finnell JS, Mischley LK. A Cross-Sectional Survey of Medical Cannabis Users: Patterns of Use and Perceived Efficacy. Cannabis Cannabinoid Res. 2016;1(1):131\u20138.","journal-title":"Cannabis and Cannabinoid Research"},{"issue":"6","key":"2803_CR64","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.drugpo.2013.08.010","volume":"24","author":"Zach Walsh","year":"2013","unstructured":"Walsh Z, Callaway R, Belle-isle L, Capler R, Kay R, Lucas P, et al. Cannabis for therapeutic purposes: Patient characteristics, access, and reasons for use. Int J Drug Policy. 2013;24(6):6\u201311.","journal-title":"International Journal of Drug Policy"},{"issue":"24","key":"2803_CR65","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1001\/jama.2015.6199","volume":"313","author":"Kevin P. Hill","year":"2015","unstructured":"Hill KP. Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems A Clinical Review. JAMA. 2015;313(24):2474\u201383.","journal-title":"JAMA"},{"key":"2803_CR66","unstructured":"National Academies of Sciences, Engineering\u00a0 and M. The Health Effects of Cannabis and Cannabinoids: The current state of evidence and recommendations for research. The National Academies Press, editor. Washington, DC; 2017."},{"key":"2803_CR67","unstructured":"Bridgeman MB, Abazia DT. Medicinal Cannabis\u202f: History, Pharmacology, And Implications for the Acute Care Setting. Pharm Ther. 2017;42(3):180\u20138."}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-019-2803-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12906-019-2803-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-019-2803-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T00:07:21Z","timestamp":1610582841000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-019-2803-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,15]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2803"],"URL":"https:\/\/doi.org\/10.1186\/s12906-019-2803-2","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,15]]},"assertion":[{"value":"27 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"\u201cNot applicable\u201d.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"\u201cNot applicable\u201d.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12"}}